Global Microbiome Drugs Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Microbiome Drugs Revenue
• 1.4 Market by Type
  • 1.4.1 Global Microbiome Drugs Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Probiotics
  • 1.4.3 Prebiotics
  • 1.4.4 Small Molecules
  • 1.4.5 Biological Drugs
  • 1.4.6 Other
• 1.5 Market by Application
  • 1.5.1 Global Microbiome Drugs Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospital Pharmacies
  • 1.5.3 Retail Pharmacies
  • 1.5.4 Online Pharmacies
  • 1.5.5 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Microbiome Drugs Market Perspective (2015-2026)
• 2.2 Global Microbiome Drugs Growth Trends by Regions
  • 2.2.1 Microbiome Drugs Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Microbiome Drugs Historic Market Share by Regions (2015-2020)
  • 2.2.3 Microbiome Drugs Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Microbiome Drugs Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Microbiome Drugs Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Microbiome Drugs Players by Market Size
  • 3.1.1 Global Top Microbiome Drugs Players by Revenue (2015-2020)
  • 3.1.2 Global Microbiome Drugs Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Microbiome Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Microbiome Drugs Market Concentration Ratio
  • 3.2.1 Global Microbiome Drugs Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Microbiome Drugs Revenue in 2019
• 3.3 Microbiome Drugs Key Players Head office and Area Served
• 3.4 Key Players Microbiome Drugs Product Solution and Service
• 3.5 Date of Enter into Microbiome Drugs Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Microbiome Drugs Historic Market Size by Type (2015-2020)
• 4.2 Global Microbiome Drugs Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Microbiome Drugs Market Size by Application (2015-2020)
• 5.2 Global Microbiome Drugs Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Microbiome Drugs Market Size (2015-2020)
• 6.2 Microbiome Drugs Key Players in North America (2019-2020)
• 6.3 North America Microbiome Drugs Market Size by Type (2015-2020)
• 6.4 North America Microbiome Drugs Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Microbiome Drugs Market Size (2015-2020)
• 7.2 Microbiome Drugs Key Players in Europe (2019-2020)
• 7.3 Europe Microbiome Drugs Market Size by Type (2015-2020)
• 7.4 Europe Microbiome Drugs Market Size by Application (2015-2020)

8 China

• 8.1 China Microbiome Drugs Market Size (2015-2020)
• 8.2 Microbiome Drugs Key Players in China (2019-2020)
• 8.3 China Microbiome Drugs Market Size by Type (2015-2020)
• 8.4 China Microbiome Drugs Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Microbiome Drugs Market Size (2015-2020)
• 9.2 Microbiome Drugs Key Players in Japan (2019-2020)
• 9.3 Japan Microbiome Drugs Market Size by Type (2015-2020)
• 9.4 Japan Microbiome Drugs Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Microbiome Drugs Market Size (2015-2020)
• 10.2 Microbiome Drugs Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Microbiome Drugs Market Size by Type (2015-2020)
• 10.4 Southeast Asia Microbiome Drugs Market Size by Application (2015-2020)

11 India

• 11.1 India Microbiome Drugs Market Size (2015-2020)
• 11.2 Microbiome Drugs Key Players in India (2019-2020)
• 11.3 India Microbiome Drugs Market Size by Type (2015-2020)
• 11.4 India Microbiome Drugs Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Microbiome Drugs Market Size (2015-2020)
• 12.2 Microbiome Drugs Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Microbiome Drugs Market Size by Type (2015-2020)
• 12.4 Central & South America Microbiome Drugs Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Pfizer
  • 13.1.1 Pfizer Company Details
  • 13.1.2 Pfizer Business Overview
  • 13.1.3 Pfizer Microbiome Drugs Introduction
  • 13.1.4 Pfizer Revenue in Microbiome Drugs Business (2015-2020))
  • 13.1.5 Pfizer Recent Development
• 13.2 Second Genome
  • 13.2.1 Second Genome Company Details
  • 13.2.2 Second Genome Business Overview
  • 13.2.3 Second Genome Microbiome Drugs Introduction
  • 13.2.4 Second Genome Revenue in Microbiome Drugs Business (2015-2020)
  • 13.2.5 Second Genome Recent Development
• 13.3 Seres Therapeutics
  • 13.3.1 Seres Therapeutics Company Details
  • 13.3.2 Seres Therapeutics Business Overview
  • 13.3.3 Seres Therapeutics Microbiome Drugs Introduction
  • 13.3.4 Seres Therapeutics Revenue in Microbiome Drugs Business (2015-2020)
  • 13.3.5 Seres Therapeutics Recent Development
• 13.4 MaaT Pharma
  • 13.4.1 MaaT Pharma Company Details
  • 13.4.2 MaaT Pharma Business Overview
  • 13.4.3 MaaT Pharma Microbiome Drugs Introduction
  • 13.4.4 MaaT Pharma Revenue in Microbiome Drugs Business (2015-2020)
  • 13.4.5 MaaT Pharma Recent Development
• 13.5 Enterome Bioscience
  • 13.5.1 Enterome Bioscience Company Details
  • 13.5.2 Enterome Bioscience Business Overview
  • 13.5.3 Enterome Bioscience Microbiome Drugs Introduction
  • 13.5.4 Enterome Bioscience Revenue in Microbiome Drugs Business (2015-2020)
  • 13.5.5 Enterome Bioscience Recent Development
• 13.6 MicroBiome Therapeutics
  • 13.6.1 MicroBiome Therapeutics Company Details
  • 13.6.2 MicroBiome Therapeutics Business Overview
  • 13.6.3 MicroBiome Therapeutics Microbiome Drugs Introduction
  • 13.6.4 MicroBiome Therapeutics Revenue in Microbiome Drugs Business (2015-2020)
  • 13.6.5 MicroBiome Therapeutics Recent Development
• 13.7 Ritter Pharmaceuticals
  • 13.7.1 Ritter Pharmaceuticals Company Details
  • 13.7.2 Ritter Pharmaceuticals Business Overview
  • 13.7.3 Ritter Pharmaceuticals Microbiome Drugs Introduction
  • 13.7.4 Ritter Pharmaceuticals Revenue in Microbiome Drugs Business (2015-2020)
  • 13.7.5 Ritter Pharmaceuticals Recent Development
• 13.8 Rebiotix
  • 13.8.1 Rebiotix Company Details
  • 13.8.2 Rebiotix Business Overview
  • 13.8.3 Rebiotix Microbiome Drugs Introduction
  • 13.8.4 Rebiotix Revenue in Microbiome Drugs Business (2015-2020)
  • 13.8.5 Rebiotix Recent Development
• 13.9 OpenBiome
  • 13.9.1 OpenBiome Company Details
  • 13.9.2 OpenBiome Business Overview
  • 13.9.3 OpenBiome Microbiome Drugs Introduction
  • 13.9.4 OpenBiome Revenue in Microbiome Drugs Business (2015-2020)
  • 13.9.5 OpenBiome Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer